To investigate whether KRT80 expression could be aberrant in patients affected by CRC we evaluated its levels using UALCAN, an online tool that analyzes the cancer OMICS data from The Cancer Genome Atlas (TCGA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC). This evidence concerns the gene KRT80 and colorectal carcinoma.